Ignite Creation Date:
2025-12-25 @ 4:33 AM
Ignite Modification Date:
2026-01-26 @ 6:15 PM
Study NCT ID:
NCT01698918
Status:
COMPLETED
Last Update Posted:
2023-05-03
First Post:
2012-10-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hormone Receptor Positive Breast Cancer | View |